These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF. Lancet; 1990 Jan 20; 335(8682):147-9. PubMed ID: 1967440 [Abstract] [Full Text] [Related]
30. Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes. Irvine WJ, Gray RS, McCallum CJ. Lancet; 1976 Nov 20; 2(7995):1097-102. PubMed ID: 62945 [Abstract] [Full Text] [Related]
32. Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes. Kolb H, Dannehl K, Grüneklee D, Zielasek J, Bertrams J, Hübinger A, Gries FA. Diabetologia; 1988 Apr 20; 31(4):189-94. PubMed ID: 3290017 [Abstract] [Full Text] [Related]
33. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A. J Clin Endocrinol Metab; 1996 Apr 20; 81(4):1488-94. PubMed ID: 8636356 [Abstract] [Full Text] [Related]
34. Prediction of the course of pre-type I diabetes. Chase HP, Garg SK, Butler-Simon N, Klingensmith G, Norris L, Ruskey CT, O'Brien D. J Pediatr; 1991 Jun 20; 118(6):838-41. PubMed ID: 2040917 [Abstract] [Full Text] [Related]
35. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease. Karjalainen JK. Diabetes; 1990 Sep 20; 39(9):1144-50. PubMed ID: 2200731 [Abstract] [Full Text] [Related]
36. Prediabetic markers in children with stress hyperglycemia. Bhisitkul DM, Vinik AI, Morrow AL, She JX, Shults J, Powers AC, Maclaren NK. Arch Pediatr Adolesc Med; 1996 Sep 20; 150(9):936-41. PubMed ID: 8790124 [Abstract] [Full Text] [Related]
37. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes. Cabrera-Rode E, Molina G, Arranz C, Vera M, González P, Suárez R, Prieto M, Padrón S, León R, Tillan J, García I, Tiberti C, Rodríguez OM, Gutiérrez A, Fernández T, Govea A, Hernández J, Chiong D, Domínguez E, Di Mario U, Díaz-Díaz O, Díaz-Horta O. Autoimmunity; 2006 Jun 20; 39(4):333-40. PubMed ID: 16891222 [Abstract] [Full Text] [Related]
38. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes. Bergerot I, Souchier C, Thivolet C. C R Acad Sci III; 1993 Nov 20; 316(11):1368-73. PubMed ID: 8087616 [Abstract] [Full Text] [Related]
39. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry. Gorus FK, Sodoyez JC, Pipeleers DG, Keymeulen B, Foriers A, Van Schravendijk CF. Diabetologia; 1992 Nov 20; 35(11):1080-6. PubMed ID: 1473619 [Abstract] [Full Text] [Related]
40. Heterogeneity of type 1 diabetes at onset in children: results from the French Incidence Study. Levy-Marchal C, Czernichow P. Diabete Metab; 1993 Nov 20; 19(3):296-303. PubMed ID: 8405620 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]